Shuttle Pharmaceuticals Holdings (SHPH) Non-Current Debt (2021 - 2023)

Shuttle Pharmaceuticals Holdings has reported Non-Current Debt for 3 years, with the latest figure at $139229.0 in Q1 2023.

• On a quarterly basis, Non-Current Debt changed N/A year-over-year to $139229.0 in Q1 2023; TTM through Mar 2023 was $139229.0, a N/A change from a year earlier, with the FY2022 full-year figure at $73007.0, changed 0.0% from the prior year.
• Non-Current Debt was $139229.0 for Q1 2023 at Shuttle Pharmaceuticals Holdings, up from $73007.0 in the prior quarter.
• The five-year high for Non-Current Debt was $139229.0 in Q1 2023, with the low at $73007.0 in Q4 2021.
• Average Non-Current Debt over 3 years is $89562.5, with a median of $73007.0 recorded in 2021.
• The largest YoY upside for Non-Current Debt was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
• Over 3 years, Non-Current Debt stood at $73007.0 in 2021, then changed by 0.0% to $73007.0 in 2022, then jumped by 90.71% to $139229.0 in 2023.
• The last three Non-Current Debt figures came in at $139229.0 (Q1 2023), $73007.0 (Q4 2022), and $73007.0 (Q3 2022), per Business Quant data.